These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Two-year follow-up study after human parvovirus B19 infection. Seishima M, Oyama Z, Yamamura M. Dermatology; 2003 Aug; 206(3):192-6. PubMed ID: 12673074 [Abstract] [Full Text] [Related]
16. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. Kalt M, Gertner E. J Rheumatol; 2001 Oct; 28(10):2335-6. PubMed ID: 11669178 [Abstract] [Full Text] [Related]
17. Human parvovirus B19: relevance in internal medicine. van Elsacker-Niele AM, Kroes AC. Neth J Med; 1999 Jun; 54(6):221-30. PubMed ID: 10399450 [Abstract] [Full Text] [Related]
18. Human parvovirus B19 infection in children: uncommon clinical presentations. Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y. Isr Med Assoc J; 2002 Oct; 4(10):763-5. PubMed ID: 12389336 [Abstract] [Full Text] [Related]
20. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients. Chen DY, Chen YM, Lan JL, Tzang BS, Lin CC, Hsu TC. Clin Chim Acta; 2012 May 18; 413(9-10):855-60. PubMed ID: 22309679 [Abstract] [Full Text] [Related] Page: [Next] [New Search]